Suspended PHASE2 INTERVENTIONAL 2-arm NCT03071653

Left Cardiac Sympathetic Denervation for Cardiomyopathy Feasibility Pilot Study (LCSD)

Left Cardiac Sympathetic Denervation (LCSD) for Cardiomyopathy Feasibility Pilot Study

Sponsor: Medtronic

Conditions Dilated Cardiomyopathy Ischemic Cardiomyopathy Non-ischemic Cardiomyopathy

Interventions Left Cardiac Sympathetic Denervation (LCSD) Optimal Medical Therapy

Updated 7 times since 2017 Last updated: May 2, 2021 Started: Nov 24, 2016 Primary completion: Nov 30, 2021 Completion: Feb 28, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Suspended

COVID and Funding

A PHASE2 clinical study on Dilated Cardiomyopathy and Ischemic Cardiomyopathy, this trial is suspended. The trial is conducted by Medtronic and has accumulated 7 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Suspended PHASE2
Jul 2024 — Sep 2024 [monthly]

Suspended PHASE2
Jun 2021 — Jul 2024 [monthly]

Suspended PHASE2

Status: Unknown Status → Suspended
Jan 2021 — Jun 2021 [monthly]

Unknown Status PHASE2
Mar 2020 — Jan 2021 [monthly]

Unknown Status PHASE2

Status: Recruiting → Unknown Status

▶ Show 2 earlier versions

Jun 2018 — Mar 2020 [monthly]

Recruiting PHASE2
May 2017 — Jun 2018 [monthly]

Recruiting PHASE2

First recorded

Nov 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medtronic
University of Cape Town

Data source: University of Cape Town

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cape Town, South Africa